Medicare Enrolled

Lyne Schaefer Alfonse, ARNP

Physician Assistant · Seattle, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1229 MADISON ST STE 1450, Seattle, WA 98104
2068446001
Registered in NPPES since 2006
NPI: 1619907110 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Schaefer Alfonse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Schaefer Alfonse? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Schaefer Alfonse

Lyne Schaefer Alfonse is a physician assistant in Seattle, WA, with 20 years of NPI registration. Based on federal Medicare data, Schaefer Alfonse performed 9,350 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Schaefer Alfonse received a total of $15,260 from 33 pharmaceutical and/or device companies across 481 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Schaefer Alfonse is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 1% volume in WA $15,260 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
9,350
Medicare services
Top 1% in WA for physician assistant
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
7,063 $11 $36
Denosumab injection (Prolia/Xgeva) 1,800 $18 $44
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
180 $70 $213
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
89 $51 $335
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
73 $11 $43
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
48 $44 $160
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
41 $110 $290
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
38 $100 $335
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
18 $16 $46
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
76.9% high complexity
20.0% medium
3.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,260
Total received (2021-2024)
Avg $3,815/year across 4 years
Top 2% in WA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
481
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,016
2023
$7,694
2022
$2,373
2021
$2,178

Payments by company (2024)

ABBVIE INC.
$767
PFIZER INC.
$464
Janssen Biotech, Inc.
$364
Amgen Inc.
$273
AstraZeneca Pharmaceuticals LP
$153
Novartis Pharmaceuticals Corporation
$139
Lilly USA, LLC
$125
Kiniksa Pharmaceuticals International, plc
$125
Aurinia Pharma U.S., Inc.
$71
Alexion Pharmaceuticals, Inc.
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
Genentech USA, Inc.
$49
GlaxoSmithKline, LLC.
$48
Radius Health, Inc.
$47
ANI Pharmaceuticals, Inc.
$47
UCB, Inc.
$46
Organon Llc
$46
Takeda Pharmaceuticals U.S.A., Inc.
$32
GENZYME CORPORATION
$27
E.R. Squibb & Sons, L.L.C.
$27
Sandoz Inc.
$22
SOBI, INC
$19
SCILEX PHARMACEUTICALS INC.
$17
Top 3 companies account for 52.9% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$5,216
PFIZER INC.
$1,933
Amgen Inc.
$1,580
ABBVIE INC.
$1,559
Novartis Pharmaceuticals Corporation
$1,421
AstraZeneca Pharmaceuticals LP
$427
Lilly USA, LLC
$421
E.R. Squibb & Sons, L.L.C.
$351
AbbVie Inc.
$307
GlaxoSmithKline, LLC.
$269
Aurinia Pharma U.S., Inc.
$237
UCB, Inc.
$211
Horizon Therapeutics plc
$173
Alexion Pharmaceuticals, Inc.
$167
Boehringer Ingelheim Pharmaceuticals, Inc.
$166
Kiniksa Pharmaceuticals International, plc
$125
Organon LLC
$123
Takeda Pharmaceuticals U.S.A., Inc.
$77
Kyowa Kirin, Inc.
$54
Genentech USA, Inc.
$49
Radius Health, Inc.
$47
ANI Pharmaceuticals, Inc.
$47
Organon Llc
$46
Ultragenyx Pharmaceutical Inc.
$44
Celltrion USA Inc.
$41
Merck Sharp & Dohme Corporation
$32
GENZYME CORPORATION
$27
TerSera Therapeutics LLC
$26
Sandoz Inc.
$22
SOBI, INC
$19
SCILEX PHARMACEUTICALS INC.
$17
Pharming Healthcare, Inc.
$15
Antares Pharma, Inc.
$15
Top 3 companies account for 57.2% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CUVITRU · CYLTEZO · Cimzia · Crysvita · EVENITY · Enbrel · HADLIMA · HUMIRA · HYRIMOZ · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · OTREXUP · Otezla · PAXLOVID · PURIFIED CORTROPHIN GEL · Quzyttir · REMICADE · RENFLEXIS · RINVOQ · RUCONEST · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPEVIGO · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tymlos · XELJANZ · YUFLYMA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a physician assistant in Seattle?
Compare physician assistants in the Seattle area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants in nearby ZIP areas
950
County median income
$122,148
Nearest hospital to ZIP centroid (approximate)
HARBORVIEW MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Schaefer Alfonse is a mixed practice specialist, with above-average Medicare volume (top 1% in WA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Schaefer Alfonse experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Schaefer Alfonse performed 7,063 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Schaefer Alfonse receive payments from pharmaceutical companies?
Yes. Schaefer Alfonse received a total of $15,260 from 33 companies across 481 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Schaefer Alfonse's costs compare to other physician assistants in Seattle?
Schaefer Alfonse's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Schaefer Alfonse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →